Breaking new ground: Digging into TERRA function

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 5, 2014, Pages 387-394

  Maicher, André ^a   Lockhart, Arianna ^a   Luke, Brian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ALT; Recombination; Survivor; Telomerase; Telomere; TERRA

Indexed keywords

RNA; TELOMERASE; TELOMERIC REPEAT CONTAINING RNA; UNCLASSIFIED DRUG;

CANCER CELL; CANCER SURVIVOR; GENE FUNCTION; GENE LOCATION; GENE REPLICATION; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; HETEROCHROMATIN; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENESCENCE; TELOMERE; TELOMERE HOMEOSTASIS; YEAST;

ALT; RECOMBINATION; SURVIVOR; TELOMERASE; TELOMERE; TERRA;

ANIMALS; CHROMATIN; DNA REPLICATION; HUMANS; RNA; TELOMERE; TRANSCRIPTION, GENETIC; YEASTS;

EID: 84903763761     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.03.012     Document Type: Review

References (97)

1. Sfeir A., de Lange T. Removal of shelterin reveals the telomere end-protection problem. Science 2012, 336(6081):593-597.
2. Lingner J., Cooper J.P., Cech T.R. Telomerase and DNA end replication: no longer a lagging strand problem?. Science 1995, 269(5230):1533-1534.
3. Lundblad V., Szostak J.W. A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 1989, 57(4):633-643.
4. Bodnar A.G., et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279(5349):349-352.
5. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345(6274):458-460.
6. O'Sullivan R.J., Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat. Rev. Mol. Cell Biol. 2010, 11(3):171-181.
7. Kaul Z., et al. Five dysfunctional telomeres predict onset of senescence in human cells. EMBO Rep. 2012, 13(1):52-59.
8. Forsyth N.R., Wright W.E., Shay J.W. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation 2002, 69(4-5):188-197.
9. Hug N., Lingner J. Telomere length homeostasis. Chromosoma 2006, 115(6):413-425.
10. Nabetani A., Ishikawa F. Alternative lengthening of telomeres pathway: recombination-mediated telomere maintenance mechanism in human cells. J. Biochem. 2011, 149(1):5-14.
11. Cesare A.J., Reddel R.R. Alternative lengthening of telomeres: models, mechanisms and implications. Nat. Rev. Genet. 2010, 11(5):319-330.
12. Abdallah P., et al. A two-step model for senescence triggered by a single critically short telomere. Nat. Cell Biol. 2009, 11(8):988-993.
13. Khadaroo B., et al. The DNA damage response at eroded telomeres and tethering to the nuclear pore complex. Nat. Cell Biol. 2009, 11(8):980-987.
14. Lundblad V., Blackburn E.H. An alternative pathway for yeast telomere maintenance rescues est1-senescence. Cell 1993, 73(2):347-360.
15. Teng S.C., Zakian V.A. Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol. Cell. Biol. 1999, 19(12):8083-8093.
16. Lydeard J.R., et al. Break-induced replication and telomerase-independent telomere maintenance require Pol32. Nature 2007, 448(7155):820-823.
17. Azzalin C.M., et al. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 2007, 318(5851):798-801.
18. Schoeftner S., Blasco M.A. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat. Cell Biol. 2008, 10(2):228-236.
19. Feuerhahn S., et al. TERRA biogenesis, turnover and implications for function. FEBS Lett. 2010, 584(17):3812-3818.
20. Cusanelli E., Chartrand P. Telomeric noncoding RNA: telomeric repeat-containing RNA in telomere biology. Wiley Interdiscip. Rev. RNA 2014, [Epub ahead of print]. 10.1002/wrna.1220.
21. Nergadze S.G., et al. CpG-island promoters drive transcription of human telomeres. RNA 2009, 15(12):2186-2194.
22. Deng Z., et al. A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. EMBO J. 2012, 31(21):4165-4178.
23. Yehezkel S., et al. Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum. Mol. Genet. 2008, 17(18):2776-2789.
24. Batenburg N.L., et al. Cockayne syndrome group B protein interacts with TRF2 and regulates telomere length and stability. Nucleic Acids Res. 2012, 40(19):9661-9674.
25. Pfeiffer V., Lingner J. TERRA promotes telomere shortening through exonuclease 1-mediated resection of chromosome ends. PLoS Genet. 2012, 8(6):e1002747.
26. Porro A., et al. Molecular dissection of telomeric repeat-containing RNA biogenesis unveils the presence of distinct and multiple regulatory pathways. Mol. Cell. Biol. 2010, 30(20):4808-4817.
27. Azzalin C.M., Lingner J. Telomeres: the silence is broken. Cell Cycle 2008, 7(9):1161-1165.
28. Luke B., et al. The Rat1p 5' to 3' exonuclease degrades telomeric repeat-containing RNA and promotes telomere elongation in Saccharomyces cerevisiae. Mol. Cell 2008, 32(4):465-477.
29. Iglesias N., et al. Subtelomeric repetitive elements determine TERRA regulation by Rap1/Rif and Rap1/Sir complexes in yeast. EMBO Rep. 2011, 12(6):587-593.
30. Balk B., et al. Telomeric RNA-DNA hybrids affect telomere-length dynamics and senescence. Nat. Struct. Mol. Biol. 2013, 20(10):1199-1205.
31. Pfeiffer V., et al. The THO complex component Thp2 counteracts telomeric R-loops and telomere shortening. EMBO J. 2013, 32(21):2861-2871.
32. Xu Y., et al. Telomeric repeat-containing RNA structure in living cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(33):14579-14584.
33. Scheibe M., et al. Quantitative interaction screen of telomeric repeat-containing RNA reveals novel TERRA regulators. Genome Res. 2013, 23:2149-2157.
34. Deng Z., et al. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol. Cell 2009, 35(4):403-413.
35. López de Silanes I., Stagno d'Alcontres M., Blasco M.A. TERRA transcripts are bound by a complex array of RNA-binding proteins. Nat. Commun. 2010, 1:33.
36. Rusche L.N., Kirchmaier A.L., Rine J. The establishment, inheritance, and function of silenced chromatin in Saccharomyces cerevisiae. Annu. Rev. Biochem. 2003, 72:481-516.
37. Gottschling D.E., et al. Position effect at S. cerevisiae telomeres: reversible repression of Pol II transcription. Cell 1990, 63(4):751-762.
38. Baur J.A., et al. Telomere position effect in human cells. Science 2001, 292(5524):2075-2077.
39. Kyrion G., et al. RAP1 and telomere structure regulate telomere position effects in Saccharomyces cerevisiae. Genes Dev. 1993, 7(7A):1146-1159.
40. Cusanelli E., Romero C.A., Chartrand P. Telomeric noncoding RNA TERRA is induced by telomere shortening to nucleate telomerase molecules at short telomeres. Mol. Cell 2013, 51(6):780-791.
41. Marion R.M., et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009, 4(2):141-154.
42. Arnoult N., Van Beneden A., Decottignies A. Telomere length regulates TERRA levels through increased trimethylation of telomeric H3K9 and HP1alpha. Nat. Struct. Mol. Biol. 2012, 19(9):948-956.
43. Farnung B.O., et al. Telomerase efficiently elongates highly transcribing telomeres in human cancer cells. PLoS One 2012, 7(4):e35714.
44. Smirnova A., et al. TERRA expression Levels do not correlate with telomere length and radiation sensitivity in human cancer cell lines. Front. Oncol. 2013, 3:115.
45. Vitelli V., et al. More on the lack of correlation between terra expression and telomere length. Front. Oncol. 2013, 3:245.
46. Caslini C., et al. MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription. Mol. Cell. Biol. 2009, 29(16):4519-4526.
47. Porro A., Feuerhahn S., Lingne J. TERRA-reinforced association of LSD1 with MRE11 promotes processing of uncapped telomeres. Cell Rep. 2014, 6(4):765-776.
48. Thijssen P.E., et al. Chromatin remodeling of human subtelomeres and TERRA promoters upon cellular senescence: commonalities and differences between chromosomes. Epigenetics 2013, 8(5):512-521.
49. Bryan T.M., et al. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 1997, 3(11):1271-1274.
50. Conomos D., Pickett H.A., Reddel R.R. Alternative lengthening of telomeres: remodeling the telomere architecture. Front. Oncol. 2013, 3:27.
51. Episkopou H., et al. Alternative lengthening of telomeres is characterized by reduced compaction of telomeric chromatin. Nucleic Acids Res. 2014, [Epub ahead of print].
52. Le P.N., et al. TERRA, hnRNP A1, and DNA-PKcs interactions at human telomeres. Front. Oncol. 2013, 3:91.
53. Biffi G., Tannahill D., Balasubramanian S. An intramolecular G-quadruplex structure is required for binding of telomeric repeat-containing RNA to the telomeric protein TRF2. J. Am. Chem. Soc. 2012, 134(29):11974-11976.
54. Xu Y., Kimura T., Komiyama M. Human telomere RNA and DNA form an intermolecular G-quadruplex. Nucleic Acids Symp. Ser. (Oxf.) 2008, (52):169-170.
55. Takahama K., et al. Regulation of telomere length by G-quadruplex telomere DNA- and TERRA-binding protein TLS/FUS. Chem. Biol. 2013, 20(3):341-350.
56. Boguslawski S.J., et al. Characterization of monoclonal antibody to DNA.RNA and its application to immunodetection of hybrids. J. Immunol. Methods 1986, 89(1):123-130.
57. Hu Z., et al. An antibody-based microarray assay for small RNA detection. Nucleic Acids Res. 2006, 34(7):e52.
58. Luna R., Rondon A.G., Aguilera A. New clues to understand the role of THO and other functionally related factors in mRNP biogenesis. Biochim. Biophys. Acta 2012, 1819(6):514-520.
59. Yu T.Y., Kao Y.W., Lin J.J. Telomeric transcripts stimulate telomere recombination to suppress senescence in cells lacking telomerase. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(9):3377-3382.
60. Sasaki T., Gilbert D.M. The many faces of the origin recognition complex. Curr. Opin. Cell Biol. 2007, 19(3):337-343.
61. Vrbsky J., et al. siRNA-mediated methylation of Arabidopsis telomeres. PLoS Genet. 2010, 6(6):e1000986.
62. Deng Z., Campbell A.E., Lieberman P.M. TERRA, CpG methylation and telomere heterochromatin: lessons from ICF syndrome cells. Cell Cycle 2010, 9(1):69-74.
63. Sudarsanam P., Winston F. The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. Trends Genet. 2000, 16(8):345-351.
64. Postepska-Igielska A., et al. The chromatin remodelling complex NoRC safeguards genome stability by heterochromatin formation at telomeres and centromeres. EMBO Rep. 2013, 14(8):704-710.
65. Santoro R., Li J., Grummt I. The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription. Nat. Genet. 2002, 32(3):393-396.
66. Zhou Y., Santoro R., Grummt I. The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription. EMBO J. 2002, 21(17):4632-4640.
67. Barrientos K.S., et al. Distinct functions of POT1 at telomeres. Mol. Cell. Biol. 2008, 28(17):5251-5264.
68. Denchi E.L., de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007, 448(7157):1068-1071.
69. Shiotani B., Zou L. ATR signaling at a glance. J. Cell Sci. 2009, 122(Pt 3):301-304.
70. Oakley G.G., Patrick S.M. Replication protein A: directing traffic at the intersection of replication and repair. Front. Biosci. (Landmark Ed) 2010, 15:883-900.
71. Dejardin J., Kingston R.E. Purification of proteins associated with specific genomic loci. Cell 2009, 136(1):175-186.
72. Schramke V., et al. RPA regulates telomerase action by providing Est1p access to chromosome ends. Nat. Genet. 2004, 36(1):46-54.
73. Luciano P., et al. RPA facilitates telomerase activity at chromosome ends in budding and fission yeasts. EMBO J. 2012, 31(8):2034-2046.
74. Flynn R.L., et al. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature 2011, 471(7339):532-536.
75. Flynn R.L., Chang S., Zou L. RPA and POT1: friends or foes at telomeres?. Cell Cycle 2012, 11(4):652-657.
76. Redon S., Reichenbach P., Lingner J. The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res. 2010, 38(17):5797-5806.
77. Yehezkel S., et al. Characterization and rescue of telomeric abnormalities in ICF syndrome type I fibroblasts. Front. Oncol. 2013, 3:35.
78. Kelleher C., Kurth I., Lingner J. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro. Mol. Cell. Biol. 2005, 25(2):808-818.
79. Loayza D., De Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 2003, 423(6943):1013-1018.
80. Wang F., et al. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 2007, 445(7127):506-510.
81. Lei M., et al. Switching human telomerase on and off with hPOT1 protein in vitro. J. Biol. Chem. 2005, 280(21):20449-20456.
82. Redon S., Zemp I., Lingner J. A three-state model for the regulation of telomerase by TERRA and hnRNPA1. Nucleic Acids Res. 2013, 41(19):9117-9128.
83. Rubtsova M.P., et al. Replication protein A modulates the activity of human telomerase in vitro. Biochemistry (Mosc) 2009, 74(1):92-96.
84. Fallet E., et al. Length-dependent processing of telomeres in the absence of telomerase. Nucleic Acids Res. 2014, 42(6):3648-3665.
85. Sandell L.L., Gottschling D.E., Zakian V.A. Transcription of a yeast telomere alleviates telomere position effect without affecting chromosome stability. Proc. Natl. Acad. Sci. U. S. A. 1994, 91(25):12061-12065.
86. Maicher A., et al. Deregulated telomere transcription causes replication-dependent telomere shortening and promotes cellular senescence. Nucleic Acids Res. 2012, 40(14):6649-6659.
87. Balk B., et al. The differential processing of telomeres in response to increased telomeric transcription and RNA-DNA hybrid accumulation. RNA Biol. 2014, 11(2).
88. Bertuch A.A., Lundblad V. EXO1 contributes to telomere maintenance in both telomerase-proficient and telomerase-deficient Saccharomyces cerevisiae. Genetics 2004, 166(4):1651-1659.
89. Maringele L., Lydall D. EXO1-dependent single-stranded DNA at telomeres activates subsets of DNA damage and spindle checkpoint pathways in budding yeast yku70Delta mutants. Genes Dev. 2002, 16(15):1919-1933.
90. Ng L.J., et al. Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res. 2009, 37(4):1152-1159.
91. Lovejoy C.A., et al. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet. 2012, 8(7):e1002772.
92. Cesare A.J., et al. Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions. Nat. Struct. Mol. Biol. 2009, 16(12):1244-1251.
93. Nabetani A., Yokoyama O., Ishikawa F. Localization of hRad9, hHus1, hRad1, and hRad17 and caffeine-sensitive DNA replication at the alternative lengthening of telomeres-associated promyelocytic leukemia body. J. Biol. Chem. 2004, 279(24):25849-25857.
94. Yeager T.R., et al. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 1999, 59(17):4175-4179.
95. Chung I., Leonhardt H., Rippe K. De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation. J. Cell Sci. 2011, 124(Pt 21):3603-3618.
96. Heaphy C.M., et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011, 333(6041):425.
97. Schwartzentruber J., et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012, 482(7384):226-231.